Publication | Open Access

Pharmacophore identification of a specific CXCR4 inhibitor, T140, leads to development of effective anti-HIV agents with very high selectivity indexes

Medicinal ChemistryMedicineHuman RetrovirusHigh Selectivity IndexesImmunologyAntiviral Drug DevelopmentAntiviral TherapySpecific Cxcr4 InhibitorPharmacotherapyPharmacophore IdentificationAntiviral DrugHivImmunotherapyPharmacologyAntiviral CompoundDrug Discovery